CAS RN: 1432597-26-6
LDN212854
Product Availability
Choose a grade to view its available package options.
8 package records6 with current stock3 grade groups
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20251105 |
1ml |
In stock |
| | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20251018 |
100mg |
Out of stock |
| | Inquiry |
| Batchno.20250813 |
10mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20250211 |
250mg |
Out of stock |
| | Inquiry |
| Batchno.20250420 |
25mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20250801 |
50mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20260622 |
5mg |
In stock |
Shanghai | | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20260430 |
1mg / 5mg / 10mg / 25mg / 100mg |
Confirm by inquiry |
Shanghai | 5-7 business days | Inquiry |
-
Product code:
starshine_CAS1432597-26-6
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
1432597-26-6 / 5-[6-(4-piperazin-1-ylphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline
Standard CAS: 1432597-26-6
Multi CAS: No
Basic Information
CAS
1432597-26-6
Multi CAS
No
Molecular Formula
C25H22N6
Molecular Weight
406.500000
Exact Mass
406.190595
SMILES
C1CN(CCN1)C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=C6C=CC=NC6=CC=C5)N=C3
InChI
InChI=1S/C25H22N6/c1-3-21(22-4-2-10-27-24(22)5-1)23-16-29-31-17-19(15-28-25(23)31)18-6-8-20(9-7-18)30-13-11-26-12-14-30/h1-10,15-17,26H,11-14H2
InChIKey
BBDGBGOVJPEFBT-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
31
Aromatic heavy atom count
25
Fraction Csp3
0.16
Rotatable bonds
3
H-bond acceptors
6
H-bond donors
1
Molar refractivity
124.24
TPSA
58.35
LogP / Solubility
WLOGP
4.02
MLOGP
3.56
XLogP3
3.3
Consensus LogP
3.63
Log S (ESOL)
-5.29
Class (ESOL)
Slightly soluble
Log S (Ali)
-5.8
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-6
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.34
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
4
Safety & Transport
Pictogram(s)
Acute Toxic
Signal
Danger
GHS Hazard Statements
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
Precautionary Statement Codes
P264, P270, P301+P316, P321, P330, P405, and P501